Jump to content
Knowledge Hub

EMA - Public Consultation ICH guideline Q14 on analytical procedure development

6th April 2022

ICH guideline Q14 on analytical procedure development - Public Consultation

This guideline applies to new or revised analytical procedures used for release and stability testing of commercial drug substances and products (chemical and biological/biotechnological). The guideline can also be applied to other analytical procedures used as part of the control strategy (ICH Q10, Pharmaceutical Quality System) following a risk-based approach. The scientific principles described in this guideline can be applied in a phase-appropriate manner during clinical development. This guideline may also be applicable to other types of products, with appropriate regulatory authority consultation as needed. Development of pharmacopoeial analytical procedures is out of scope.

View Now

Comments should be provided using this  template and sent to ich@ema.europa.euby 31 July 2022.

Back to News Archive


Virtual Event Platform